ResMed (RMD) Tops Q3 EPS by 20c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $203.87 -2.2%
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.13, $0.20 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.17 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- UBS Reiterates Buy Rating on Dollar Tree (DLTR)
- Occidental Petroleum releases Q2 2026 earnings considerations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
